199.81MMarket Cap-1831P/E (TTM)
10.2000High9.8000Low45.79KVolume9.9900Open10.0300Pre Close455.76KTurnover0.30%Turnover RatioLossP/E (Static)20.00MShares22.313652wk High1.00P/B150.90MFloat Cap6.500052wk Low--Dividend TTM15.11MShs Float128.4400Historical High--Div YieldTTM3.99%Amplitude6.5000Historical Low9.9520Avg Price1Lot Size
Cybin Stock Forum
EXCLUSIVE: Cybin Tells Benzinga Co. Announces Grant Of First U.S Composition of Matter Patent N Support Of Its CYB005 Phenethylamines Program
"Wait… did the DEA just tell us to double the supply of… drugs?! 😂 Looks like even the feds are bullish on psychedelics and THC. 🚀📈 Time to buy more $SNDL and invest in snack companies for the real winners! 🍕👀
loading...
4 mins ago
Cybin Inc: 12-Month Efficacy Data From Phase 2 Study of Cyb003 in Mdd Expected in Early Q4 2024
Cybin Inc -Phase 2 Topline Efficacy and Safety Results for Cyb004 in Generalized Anxiety Disorder ("Gad") Expected Year-End 2024 or Early Q1 2025
迷幻药品市场预计到2028年将增长137亿美元,受精神健康障碍和人工智能整合驱动
No comment yet